G. Sas

1.2k total citations
26 papers, 908 citations indexed

About

G. Sas is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, G. Sas has authored 26 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cancer Research. Recurrent topics in G. Sas's work include Blood Coagulation and Thrombosis Mechanisms (16 papers), Protease and Inhibitor Mechanisms (5 papers) and Blood properties and coagulation (4 papers). G. Sas is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (16 papers), Protease and Inhibitor Mechanisms (5 papers) and Blood properties and coagulation (4 papers). G. Sas collaborates with scholars based in United Kingdom, Hungary and Canada. G. Sas's co-authors include Judith Belle Brown, Barbara Lent, Géraldine Schmidt, Linda L. Pederson, Dénes Bánhegyi, János Jakó, G Blaskó, David A. Lane, S.C. Bock and R.J. Olds and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Blood.

In The Last Decade

G. Sas

24 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Sas United Kingdom 12 405 330 188 150 133 26 908
Christopher S. Parker United States 10 224 0.6× 42 0.1× 40 0.2× 35 0.2× 259 1.9× 14 1.2k
Deanna Teoh United States 18 19 0.0× 88 0.3× 64 0.3× 89 0.6× 115 0.9× 74 1.1k
Straus 2 26 0.1× 184 0.6× 108 0.6× 140 0.9× 47 0.4× 2 500
Katherine C. Saunders United States 16 134 0.3× 70 0.2× 99 0.5× 80 0.5× 143 1.1× 36 994
Vinay Gupta United States 14 168 0.4× 107 0.3× 36 0.2× 39 0.3× 57 0.4× 31 789
Laura DeCastro United States 11 661 1.6× 71 0.2× 29 0.2× 46 0.3× 36 0.3× 24 1.0k
Emma Slaytor Australia 9 14 0.0× 64 0.2× 112 0.6× 58 0.4× 151 1.1× 10 533
Elizabeth Anionwu United Kingdom 16 262 0.6× 16 0.0× 63 0.3× 61 0.4× 161 1.2× 55 920
J. L. Levin United States 9 66 0.2× 334 1.0× 142 0.8× 247 1.6× 114 0.9× 15 725
Rebecca Stack United Kingdom 20 194 0.5× 34 0.1× 50 0.3× 94 0.6× 128 1.0× 44 987

Countries citing papers authored by G. Sas

Since Specialization
Citations

This map shows the geographic impact of G. Sas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Sas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Sas more than expected).

Fields of papers citing papers by G. Sas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Sas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Sas. The network helps show where G. Sas may publish in the future.

Co-authorship network of co-authors of G. Sas

This figure shows the co-authorship network connecting the top 25 collaborators of G. Sas. A scholar is included among the top collaborators of G. Sas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Sas. G. Sas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Judith Belle, et al.. (2001). [Screening for violence against women. Validation and feasibility studies of a French screening tool].. PubMed. 47. 988–95. 11 indexed citations
2.
Pabinger, Ingrid, László Nemes, C. Rintelen, et al.. (2000). Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. The Hematology Journal. 1(1). 37–41. 53 indexed citations
3.
Losonczy, Hajna, et al.. (2000). Identification of mutations in 15 Hungarian families with hereditary protein C deficiency. British Journal of Haematology. 111(1). 129–135. 2 indexed citations
4.
Losonczy, Hajna, et al.. (2000). Identification of mutations in 15 Hungarian families with hereditary protein C deficiency. British Journal of Haematology. 111(1). 129–135. 8 indexed citations
5.
Brown, Judith Belle, Barbara Lent, Géraldine Schmidt, & G. Sas. (2000). Application of the Woman Abuse Screening Tool (WAST) and WAST-short in the family practice setting.. PubMed. 49(10). 896–903. 151 indexed citations
6.
Brown, Judith Belle, et al.. (1996). Development of the Woman Abuse Screening Tool for use in family practice.. PubMed. 28(6). 422–8. 171 indexed citations
7.
Gruber, András, John H. Griffin, A. Pál, G. Sas, & Róbert Gábor Kiss. (1993). Generation of activated protein C during thrombolysis. The Lancet. 342(8882). 1275–1276. 24 indexed citations
8.
Olds, R.J., David A. Lane, M Boisclair, et al.. (1992). Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F. FEBS Letters. 300(3). 241–246. 47 indexed citations
9.
Lane, David A., R.J. Olds, J. Conard, et al.. (1992). Pleiotropic effects of antithrombin strand 1C substitution mutations.. Journal of Clinical Investigation. 90(6). 2422–2433. 75 indexed citations
10.
Lane, David A., Maria Panico, Huw R. Morris, et al.. (1992). Antithrombin III Budapest: a single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family. Blood. 79(5). 1206–1212. 42 indexed citations
11.
Ezban, Mirella, et al.. (1990). Purification and characterisation of the pathological antithrombin III “Aalborg”. Thrombosis Research. 57(5). 807–812. 2 indexed citations
12.
Sas, G.. (1987). DEFECTS IN SERINE PROTEASE INHIBITORS. Thrombosis and Haemostasis. 4 indexed citations
13.
14.
Sas, G., et al.. (1979). Heparin-Affinity of Antithrombin III in a Family With Congenital Antithrombin III Deficiency. Thrombosis and Haemostasis. 1 indexed citations
15.
Sas, G., et al.. (1977). Detection of Antithrombin III /AT-III/ Complexes in “Hypercoagulable” and Hyper-Fibrinolytic States. Thrombosis and Haemostasis. 4 indexed citations
16.
Sas, G., et al.. (1974). Abnormal Antithrombin III (Antithrombin III ‘Budapest’) as a Cause of a Familial Thrombophilia. Thrombosis and Haemostasis. 32(1). 105–115. 147 indexed citations
17.
Sas, G., G Blaskó, János Jakó, & Dénes Bánhegyi. (1973). Inhibitory effect of "late" type fibrinogen degradation products (FDP) upon the ethanol gelation of plasma.. PubMed. 7(3). 369–74. 1 indexed citations
18.
Sas, G., et al.. (1971). A Rapid Method for the Semiquantitative Determination of Fibrinogen and Fibrinogen Degradation Products (FDP) in Defibrination Syndrome. Thrombosis and Haemostasis. 25(3). 555–565. 2 indexed citations
19.
Sas, G., et al.. (1969). Reaction Kinetics of Thrombin Activity in Decalcified Plasma and Blood. Thrombosis and Haemostasis. 21(3). 580–593. 1 indexed citations
20.
Sas, G., et al.. (1966). Changes of Heparin-Antithrombin Activity in Rats with Adjuvant Arthritis. Acta Rheumatologica Scandinavica. 12(1-4). 95–101. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026